While some pediatric brain cancers have known genetic causes, many do not. Three-dimensional profiling revealed new disease mechanisms and drug targets.
Small molecule drugs that trigger the death of cells storing latent viruses are a promising approach for treating HIV. Researchers identified a potent compound in a marine sponge — a more likely source than it may seem.
There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.
From ancient medicines to equipping humans with new senses, tattoos are more than just permanent marks on the skin. They may boost immune function, and they have the potential to effectively deliver therapeutics through the skin.
To avoid the pain, scars, and complications of traditional skin grafts and sutures, scientists take inspiration from mussels, some of the stickiest, most resilient animals on Earth.
COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.